STERIS-STE Beats on Q1 Earnings and Revenues, Raises '26 Sales View

Key Takeaways STE reported Q1 adjusted EPS of $2.34, up 15.3% year over year and above consensus estimate.STE's revenues grew 8.6% to$ 1.39B, driven by gains across Healthcare, AST and Life Sciences segments.STE raised FY26 revenue growth guidance to 8-9%, with adjusted EPS forecast of $9.90-$ 10.15.STERIS plc (STE) reported first-quarter fiscal 2026 adjusted earnings per share (EPS) of $2.34, up 15.3% from the year-ago quarter’s figure. The figure surpassed the Zacks Consensus Estimate by 0.9%.The adjustmen ...